iRay Technology Unit to Raise 50 Million Yuan from Investment Fund

MT Newswires Live

Sep 15

iRay Technology (SHA:688301) said its controlled grandchild company iRay New Materials will introduce Shanghai Lianxin Medical and Health M&A Private Equity Investment Fund as an investor through a 50-million-yuan capital increase.

The fund will contribute 50 million yuan for 2.5 million yuan in newly registered capital, taking a 10% stake in iRay New Materials.

iRay Taicang will waive its preemptive subscription right, with its holding in iRay New Materials dropping to 57.36% from 63.74%.

Shares of iRay Technology were up nearly 2% in recent trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2667110386"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2667110386\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2667110386?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-15 14:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2667110386","market":"sh","top_or_hot":-1,"title":"iRay Technology Unit to Raise 50 Million Yuan from Investment Fund","media":"MT Newswires Live","content":"<html><body><p> iRay Technology (SHA:688301) said its controlled grandchild company iRay New Materials will introduce Shanghai Lianxin Medical and Health M&amp;A Private Equity Investment Fund as an investor through a 50-million-yuan capital increase.</p><p>The fund will contribute 50 million yuan for 2.5 million yuan in newly registered capital, taking a 10% stake in iRay New Materials.</p><p>iRay Taicang will waive its preemptive subscription right, with its holding in iRay New Materials dropping to 57.36% from 63.74%.</p><p>Shares of iRay Technology were up nearly 2% in recent trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>iRay Technology Unit to Raise 50 Million Yuan from Investment Fund</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\niRay Technology Unit to Raise 50 Million Yuan from Investment Fund\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-09-15 14:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> iRay Technology (SHA:688301) said its controlled grandchild company iRay New Materials will introduce Shanghai Lianxin Medical and Health M&amp;A Private Equity Investment Fund as an investor through a 50-million-yuan capital increase.</p><p>The fund will contribute 50 million yuan for 2.5 million yuan in newly registered capital, taking a 10% stake in iRay New Materials.</p><p>iRay Taicang will waive its preemptive subscription right, with its holding in iRay New Materials dropping to 57.36% from 63.74%.</p><p>Shares of iRay Technology were up nearly 2% in recent trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0251","symbol_name":"专用设备","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2667110386","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2667110386","pubTimestamp":1789454879,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"iRay Technology  said its controlled grandchild company iRay New Materials will introduce Shanghai Lianxin Medical and Health M&A Private Equity Investment Fund as an investor through a 50-million-yuan capital increase.The fund will contribute 50 million yuan for 2.5 million yuan in newly registered capital, taking a 10% stake in iRay New Materials.iRay Taicang will waive its preemptive subscription right, with its holding in iRay New Materials dropping to 57.36% from 63.74%.Shares of iRay Technology were up nearly 2% in recent trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688301":"奕瑞科技","BK0251":"专用设备","FCA":"First Trust China AlphaDEX Fund"},"translate_title":"iRay Technology将从投资基金中募集5000万元人民币","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688301":0.9,"FCA":0.72},"content_text":"iRay Technology (SHA:688301) said its controlled grandchild company iRay New Materials will introduce Shanghai Lianxin Medical and Health M&A Private Equity Investment Fund as an investor through a 50-million-yuan capital increase.The fund will contribute 50 million yuan for 2.5 million yuan in newly registered capital, taking a 10% stake in iRay New Materials.iRay Taicang will waive its preemptive subscription right, with its holding in iRay New Materials dropping to 57.36% from 63.74%.Shares of iRay Technology were up nearly 2% in recent trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}